<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04992325</url>
  </required_header>
  <id_info>
    <org_study_id>2021/07</org_study_id>
    <nct_id>NCT04992325</nct_id>
  </id_info>
  <brief_title>AS-OCT Study in Diabetic Retinopathy</brief_title>
  <official_title>Anterior Segment- Optical Coherence Tomography as Early Biomarker in Diabetic Retinopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the corneal features using anterior segment - optical coherence&#xD;
      tomography in patients affected by type 2 diabetes mellitus&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate the potential role of anterior segment-optical coherence tomography (AS-OCT)&#xD;
      in identifying the corneal changes (in particular in total corneal, epithelial and stromal&#xD;
      thicknesses) in patients affected by type 2 diabetes mellitus, without signs of diabetic&#xD;
      retinopathy at fundus examination.&#xD;
&#xD;
      The AS-OCT could represents a valid early biomarker in these patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Actual">April 30, 2021</completion_date>
  <primary_completion_date type="Actual">April 25, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The measurements of corneal features in patients with type 2 diabetes mellitus, using anterior segment-optical coherence tomography</measure>
    <time_frame>twelve months</time_frame>
    <description>The parameters analyzed by anterior segment-optical coherence tomography angiography were: total corneal, epithelial and stromal thicknesses</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Patients with type 2 diabetes mellitus</arm_group_label>
    <description>The patients with previous diagnosis of type 2 diabetes mellitus, without signs of diabetic retinopathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <description>Healthy subjects without actual and previous ocular diseases</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Anterior segment-optical coherence tomography</intervention_name>
    <description>Each subject underwent anterior segment -optical coherence tomography to evaluate the total corneal, epthelium and stromal thicknesses.</description>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_label>Patients with type 2 diabetes mellitus</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The participans were older than 50 years with previous diagnosis of type 2 diabetes&#xD;
        mellitus without signs of diabetic retinopathy.&#xD;
&#xD;
        The participans did not present other ophthalmological diseases&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age older than 50 years&#xD;
&#xD;
          -  diagnosis of previous type 2 diabetes mellitus&#xD;
&#xD;
          -  absence of signs of diabetic retinopathy&#xD;
&#xD;
          -  absence of previous ocular surgery, congenital eye disease, high myopia (&gt;6 dioptres),&#xD;
             actual or previous diagnosis of glaucoma, optic disc anomaly, macular or vitreoretinal&#xD;
             diseases.&#xD;
&#xD;
          -  absence of significant lens opacities, low-quality OCT and OCT-A images&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age younger than 50 years&#xD;
&#xD;
          -  absence of previous diagnosis of type 2 diabetes mellitus&#xD;
&#xD;
          -  presence of signs of diabetic retinopathy&#xD;
&#xD;
          -  presence of previous ocular surgery, congenital eye disease, high myopia (&gt;6&#xD;
             dioptres), actual or previous diagnosis of glaucoma, optic disc anomaly, macular or&#xD;
             vitreoretinal diseases.&#xD;
&#xD;
          -  presence of significant lens opacities, low-quality OCT and OCT-A images.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Gilda Cennamo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federico II University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Naples &quot;Federico II&quot;</name>
      <address>
        <city>Naples</city>
        <zip>80100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 25, 2021</study_first_submitted>
  <study_first_submitted_qc>July 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2021</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Gilda Cennamo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

